Search

Author/Creator Cloutier, S.

1. A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII. Issue 2 (1st February 2018)

Authors:
Dubé, E.; Bonnefoy, A.; Merlen, C.; Castilloux, J.‐F.; Cloutier, S.; Demers, C.; Sabapathy, C. A.; St‐Louis, J.; Vezina, C.; Warner, M.; Rivard, G.‐É.
Journal:
Haemophilia
Issue:
Volume 24:Issue 2(2018)
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS). (July 2015)

Authors:
Langley, A. R.; Stain, A. M.; Chan, A.; McLimont, M.; Chait, S.; Wu, J.; Poon, M.‐C.; Card, R.; Israels, S. J.; Laferriere, N.; Klaassen, R. J.; Rivard, G. E.; Cloutier, S.; Hawes, S.; Feldman, B.; Blanchette, V.
Journal:
Haemophilia
Issue:
Volume 21:Number 4(2015:Jul.)
Page Start:
469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗